Affymetrix, Inc. (NASDAQ:AFFX)

CAPS Rating: 2 out of 5

Engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets and create tools that advances the understanding of the molecular basis of life.

Results 1 - 20 of 58 : 1 2 3 Next »

Recs

0
Member Avatar pchop123 (78.31) Submitted: 4/14/2014 11:04:08 AM : Outperform Start Price: $6.83 AFFX Score: +3.60

upside now the right call

Recs

0
Member Avatar yooperking (74.75) Submitted: 3/12/2014 10:27:39 AM : Outperform Start Price: $7.55 AFFX Score: -4.41

This stock is dirt cheap relative to others in its industry:
Price/Sales (ttm): 1.61
Price/Book (mrq): 1.95
The shorts representing 18.2% of the outstanding shares are in peril of getting squeezed, when this company becomes a buyout target.

Recs

3
Member Avatar zzlangerhans (99.73) Submitted: 2/6/2014 2:15:09 PM : Outperform Start Price: $7.04 AFFX Score: -3.39

Affymetrix is down big after the most recent earnings, but the numbers don't look bad to me. Revenues were 93M, up from 80M in the last quarter. The revenue increases seem equitably distributed across the segments, with the exception of flat sales from eBioscience. There was no obvious bad news regarding future trands as far as I could tell, and in fact a new test recently received 510 (k) approval from the FDA. Of course, the stock did more than double over the last few months despite rather pedestrian earnings growth so perhaps this decline just represents momentum traders growing bored with the stock. There's still a ways to go to fill the gap if that's what's destined to occur, so I'll keep my real money on the sidelines for now and see where the drop levels off.

Recs

0
Member Avatar RBuskey106 (63.41) Submitted: 4/9/2012 1:54:37 PM : Outperform Start Price: $4.15 AFFX Score: +38.38

Chart Play

Recs

0
Member Avatar stainsolution (71.46) Submitted: 4/9/2012 1:26:34 PM : Outperform Start Price: $4.15 AFFX Score: +38.38

Chart Play

Recs

0
Member Avatar seyer (< 20) Submitted: 2/13/2012 1:46:02 PM : Outperform Start Price: $4.65 AFFX Score: +17.13

Affy chips are paving the way for personalized medicine.

Recs

0
Member Avatar KimLanners (< 20) Submitted: 7/7/2011 11:05:06 AM : Underperform Start Price: $6.49 AFFX Score: +26.99

this is going to 5$!

Recs

0
Member Avatar geo11zak (23.74) Submitted: 12/16/2010 8:14:47 AM : Outperform Start Price: $4.50 AFFX Score: +9.90

valuation, great potential

Recs

0
Member Avatar KR1527 (< 20) Submitted: 10/20/2010 2:10:34 PM : Outperform Start Price: $4.53 AFFX Score: +1.08

Deeply oversold and about to return to profitability so the stock should get above $6 in the next 3-12 months.

Recs

0
Member Avatar whomonkyoulus (28.68) Submitted: 10/13/2010 4:15:51 PM : Outperform Start Price: $4.52 AFFX Score: +1.08

Insider buys. Growth sector.
Cash flows do not show the grim picture than accounting does.

Recs

0
Member Avatar franktejon (< 20) Submitted: 7/7/2010 10:25:05 PM : Outperform Start Price: $4.14 AFFX Score: -0.28

strong buy

Recs

0
Member Avatar lytri (83.41) Submitted: 7/7/2010 1:49:38 PM : Outperform Start Price: $4.14 AFFX Score: -3.38

Knocked down quite badly today, but genetic testing is ramping up. As it becomes more common for companies to turn to this, AFFX will continue to grow.

Recs

0
Member Avatar elica (< 20) Submitted: 2/18/2010 10:58:45 AM : Outperform Start Price: $7.65 AFFX Score: -74.62

great tech signs

Recs

0
Member Avatar ipfmanager (94.38) Submitted: 11/16/2009 5:45:38 PM : Outperform Start Price: $5.20 AFFX Score: -29.58

nih grant

Recs

1
Member Avatar PatrickDickey (65.60) Submitted: 8/6/2009 1:29:20 AM : Outperform Start Price: $9.30 AFFX Score: -108.33

I'm counting on AFFX to innovate in the field of Genetic mapping, and bring their prices down to the same level or at least a more fitting level for their products. Plus, with the other Genetic Mapping companies in the game, I think they will all benefit in the next five years or so.

Recs

0
Member Avatar 108600 (< 20) Submitted: 8/2/2009 2:11:08 PM : Outperform Start Price: $9.04 AFFX Score: -107.86

semiconductor sector starting to turn up.

Recs

1
Member Avatar John789 (28.81) Submitted: 8/1/2008 6:41:29 PM : Outperform Start Price: $8.41 AFFX Score: -66.92

can't get any lower

Recs

0
Member Avatar biovestor (< 20) Submitted: 6/28/2008 4:00:08 PM : Outperform Start Price: $10.03 AFFX Score: -78.55

An out-of-favor provider of research tools and systems for genetic analysis that is poised to regain investor favor due to the need for innovation in biotech and pharma industry.

Recs

0
Member Avatar alex0144a (< 20) Submitted: 6/26/2008 12:06:53 PM : Outperform Start Price: $10.16 AFFX Score: -77.72

the stock has been beaten up and the chart is positive

Recs

0
Member Avatar itainvestor (94.19) Submitted: 5/27/2008 3:39:17 PM : Outperform Start Price: $11.85 AFFX Score: -78.38

Rule Breaker, Insiders, Sector bet

Results 1 - 20 of 58 : 1 2 3 Next »

Featured Broker Partners


Advertisement